Hakim (@hakim034) header
Hakim (@hakim034) profile picture

Microbiologist

Joined July 2010
Photo by Hakim (@hakim034)Photo by Hakim (@hakim034)Photo by Hakim (@hakim034)Photo by Hakim (@hakim034)Photo by Hakim (@hakim034)Photo by Hakim (@hakim034)Photo by Hakim (@hakim034)Photo by Hakim (@hakim034)Photo by Hakim (@hakim034)Photo by Hakim (@hakim034)
Bio: "I don't want to over-hype this too much but our work might possibly someday contribute to improving the standard of care for a subset of lymphoma patients" Tech: "AI will cure all diseases very soon"
14
42
11
443
61,974
Rubisco is (arguably) the most abundant protein on Earth. (LPP surely comes close, right?) It’s an enzyme that fixes COā‚‚ into sugars during photosynthesis. Unfortunately, as most people learn in school, Rubisco is inefficient. Sometimes it confuses Oā‚‚ for COā‚‚ and wastes energy. Plants make up for this in raw concentration; up to half the soluble protein in a leaf is Rubisco. People have been trying to engineer better Rubiscos for many decades, but it's not easy because the proteins are big, do not fold easily (they need chaperone proteins to help out), are made from 16 subunits in land plants. But there's a new paper in Nature Plants that looks really interesting. The TL;DR is that a group in Australia figured out how to express plant Rubiscos (and all SEVEN of their folding chaperones) using a set of 3 plasmids inside of E. coli cells. This enabled them to do "directed evolution" of Rubisco in bacterial cells, and quickly find Rubisco mutants that have higher enzymatic efficiency or that fold better. In addition to the 3 plasmids, the researchers also coaxed E. coli to make ribulose-1,5-biphosphate, or RuBP, which is the 5-carbon sugar that Rubisco smashes into carbon dioxide to make molecules of 3-PGA for central metabolism. Now, the clever bit is that you RANDOMLY MUTATE the three plasmids encoding the Rubisco to make millions of variants. Then, you transform those mutated plasmids into E. coli. If the E. coli do NOT make a functional Rubisco, RuBP levels build up and kill the cell; the molecule becomes toxic. But if the E. coli DO make a functional Rubisco, then they keep the RuBP levels in check and live just fine. Using this "screening assay," the researchers found 46 fast-growing colonies of E. coli. Two of those colonies encoded really useful mutations. One mutation (M116L) makes Rubisco about 25–40% faster. The other (A242V) makes it fold and assemble much more efficiently. They put this mutation into a "hybrid Arabidopsis–tobacco Rubisco," put that into tobacco plants, and measured growth. The plants with M116L grew 75% faster than wildtype. No guarantees this will scale to more useful crops, like wheat and corn and soybeans etc. But it seems like a nice in vitro assay for faster prototyping!
37
388
67
2,196
142,085
Undruggable ā€˜disordered’ proteins become druggable with new AI techniques from David Baker. @ScienceMagazine science.org/doi/10.1126/scie…
5
150
8
595
72,986
Understanding probability is essential in data science. In 4 minutes, I'll demolish your confusion. Let's go!
18
400
8
2,713
292,213
A synthetic small molecule, C26, inhibits Salmonella pathogenicity by targeting the disease’s major secretion systems, according to new research. scim.ag/3XREHEN
1
5
1,795
šŸŽ„CMFI board member @lab_maier recently featured in documentary on bacteria. She and her lab members provide insights into the current state of microbiome research and explain the work with bacteria in the laboratory. ardmediathek.de/video/gut-zu… @uni_tue @uni_tue_exstra @BR_Presse
1
4
14
1,247
Another mind-blower from the Saitou lab doi.org/10.1038/s41586-024-0…
9
38
7,783
Very interesting study (with link to overview) that shows that 86% of surgical site infections (spinal surgery) arise from bacteria present in the patient's microbiome, not externally. science.org/doi/10.1126/scit…
1
7
30
2,610
The T4bSS of Legionella features a two-step secretion pathway with an inner membrane intermediate for secretion of transmembrane ... biorxiv.org/cgi/content/shor… #biorxiv_micrbio
4
10
1,428
Why are some non-antibiotic drugs toxic to bacteria šŸ’Šā˜ ļøšŸ¦ ? Do they work like standard #antibiotics (ABX)? Our latest work by @MarianaNoto published @ScienceMagazine addresses this fundamental question (1/n) science.org/doi/10.1126/scie…
11
100
11
312
80,618
Why don't humans have tails? A genetics study finds that a mobile genetic sequence inserted into a gene for tail development contributed to tail loss as early apes evolved. Miriam Konkel and @EmLyWill unpack the results. go.nature.com/3uN6lr9
3
20
59
19,353
LibĆ©ration d’Ihsane El Kadi : Des personnalitĆ©s algĆ©riennes adressent une lettre ouverte au prĆ©sident radio-m.net/liberation-dihsa…
6
41
6
107
7,208
NEW: analysis of millions of books published over the centuries suggests western society is shifting away from a culture of progress, and towards one of caution, worry and risk-aversion. I think this is one of the most important challenges facing us today.
431
2,232
1,091
8,667
3,814,333
A new antibiotic traps lipopolysaccharide in its intermembrane transporter | Nature nature.com/articles/s41586-0…
65
1
253
21,815
Check out this new study in @Nature: Fungal infections pose a huge health threat and there are very few specific antifungal drugs. Here, the rational improvement of amphotericin B led to a drug that kills fungi but has low toxicity towards kidney cellsšŸŽÆ nature.com/articles/s41586-0…
2
32
3
117
23,961